Why the study?
Does methoxamine injection during right heart catheterization accurately diagnose mitral insufficiency?
Does methoxamine injection during right heart catheterization accurately diagnose mitral insufficiency?
Methoxamine injection during right heart catheterization has limited diagnostic value for mitral insufficiency due to overlapping hemodynamic responses across different patient groups.
Answers are grounded in this paper and cite their sources.
Limited diagnostic utility of methoxamine Δv/ΔA testing cautions against reliance for mitral insufficiency; leaves open need for validated hemodynamic criteria.
The effect of methoxamine on PCV pressure has been examined in 47 cases (24 with mitral valvular disease, 2 with aortic insufficiency, 12 with congenital heart disease, and 9 with no organic heart disease). The rise in v‐peak pressure related to the elevation in systemic arterial pressure (Δv/ΔA ratio) after methoxamine injection was measured. The ratio usually was higher in patients with mitral insufficiency than in other cases, but a marked overlapping was seen between the different patient groups. The methoxamine test during routine cardiac catheterization is therefore of limited value in the diagnosis of mitral insufficiency. A marked bradycardia was seen after methoxamine infusions in most cases. Four patients had transient conduction disturbances, but no serious complications were encountered. The effect of methoxamine on cardiac output was recorded in 13 cases. Methoxamine did not influence cardiac output significantly.
No takes yet. Share an insight, caveat, or question.
Grendahl et al. (1971) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: